drugset / Press release
Emergent BioSolutions Initiates Phase 1b Study of TRU-016 in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia
2012-10-31 · Emergent BioSolutions · original emergentbiosolutions.com ↗
Oct. 31 2012 - Phase 1 Initiation TRU-016 Combo Rituximab (FINAL).pdf 52.1 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗